Impact of CD33 and ABCB1 single nucleotide polymorphisms in patients with acute myeloid leukemia and advanced myeloid malignancies treated with decitabine plus gemtuzumab ozogamicin.
Nicholas James ShortGuillaume Richard-CarpentierRashmi Kanagal-ShamanaKeyur P PatelMarina Y KonoplevaIoannis PapageorgiouNaveen PemmarajuGautam BorthakurFarhad RavandiCourtney D Di NardoTapan Mahendra KadiaHagop M KantarjianJatinder K LambaNaval G DaverPublished in: American journal of hematology (2020)